Partner
Andrew Farnum
Other at Laerdal Million Lives Fund
- Firm
- Laerdal Million Lives Fund
- Role
- Other
Claim, correct or request removal
Record updated 18 September 2026
About
Andrew is the CEO of Variant Bio, a developer of therapeutics that improve global health by studying the genes of people with exceptional health-related traits. He was previously the director of the Gates Foundation Strategic Investment Fund.
Is this you? Remove my profile
Loading relationship preview